This policy controls how the atlas describes product labels, research exposures, and the boundary beyond which evidence reporting would become personal instruction.
Three distinct concepts
Approved labeled regimen — a regulator-reviewed regimen for a named product, jurisdiction, indication, route, and population. Cite the current label and its date.
Studied exposure — exposure used in a particular registered or published study. It describes research; it is not a recommendation and may have failed or caused harm.
Personal recommendation — selection or adaptation for an individual is outside atlas scope.
An unsubstantiated marketed regimen is a schedule promoted without adequate authoritative support. It is recorded only when necessary to analyze misinformation, labeled unsupported, and never turned into a usable protocol.
- Approved labeled regimen: product, jurisdiction, indication, population, route, and label date.
- Studied exposure: study population, design, exposure, endpoint, and limitation.
- Personal recommendation: outside atlas scope.
Required wording
Unapproved or A clinical-stage candidate with scientific or public relevance. Investigation is not approval, and a studied exposure is not a recommendation. Quelle der Definition: Scope and selection methodology · Glossar material
No established or recommended human dose.
Evidence from in vitro or animal studies with no adequate human efficacy evidence — the atlas Grade D lane. Quelle der Definition: Evidence grading methodology · Glossar-only evidence
No adequate human dosing evidence; animal exposure must not be converted into a self-experimentation regimen.
Approved medicine
The label summary below is product-, indication-, and jurisdiction-specific; consult the full current label and a licensed clinician/pharmacist.
| Evidence situation | Required atlas label | Required qualifiers | Forbidden inference |
|---|---|---|---|
| Approved labeled regimen | Approved-label wording from the current official label | Named product, jurisdiction, indication, population, route, and label date | That the wording applies to another product, use, place, population, or date |
| Studied exposure | Descriptive research exposure; if no approved human use exists, state No established or recommended human dose. | Study population, design, exposure, endpoint, result, and limitations | That a studied exposure is advice, a successful regimen, or evidence of approval |
| Personal recommendation or unsupported marketed schedule | Outside atlas scope or unsupported, as applicable | Explain the evidence or misinformation boundary without operational detail | Any individualized instruction or conversion into a usable protocol |
The evidence-grading method evaluates the support for a claim without changing these language boundaries. For official documents, use the approved-product label index; for conceptual arithmetic and interpretation limits, see dose-math and calculator literacy. The distinction between marketed and authorized material is also developed in Research Market vs Approved Peptides. The studied and labeled exposures index applies this policy across the whole atlas: every compound's labeled regimen or studied exposure is listed with its framing, and compounds without an established dose say so plainly.
Ask whether a current official label covers this exact product and claim. If yes, use approved-label wording with its scope and date. If not, ask whether a human study exists: describe the studied exposure without advice, or state what is not established. All routes end with no individualized instruction.
Prohibited transformations
Scope transfer
selecting a route or transferring wording to a different product, indication, jurisdiction, or population;
inferring vial concentration, sterility, compatibility, beyond-use dating, or storage from a vendor listing.
Species transfer
converting animal exposure into human amounts or a self-experimentation regimen.
Personalization
calculating a personal regimen or prescribing a titration;
expressing a desired amount as syringe units;
providing cycle or stack plans.
These exclusions keep the page methodological: the atlas reports what a source establishes without converting it into personal instructions.